首页> 外国专利> THERAPEUTIC COMPOSITION CONTAINING VASO- CONSTRICTING ALPHA STIMULATING AGENT AS POSITIVE FACTOR FOR PREVENTING AND TREATING WORSENING OF CONDITION OF CARDIAC DEFICIENCY

THERAPEUTIC COMPOSITION CONTAINING VASO- CONSTRICTING ALPHA STIMULATING AGENT AS POSITIVE FACTOR FOR PREVENTING AND TREATING WORSENING OF CONDITION OF CARDIAC DEFICIENCY

机译:包含血管强化阿尔法刺激剂的治疗性组合物,作为预防和治疗心脏疾病状态恶化的积极因素

摘要

PURPOSE: To prepare a therapeutic agent for cardiac diseases in a form of inhalation by including 2-amino-1-(2,5-dimethoxyphenyl)1-propanol. CONSTITUTION: The objective composition is obtained by dissolving 2- amino-1-(2,5-dimethoxyphenyl)-1-propanol and a salt thereof in a physiological solution to form 0.1-10% (W/V), prefearbly 2-5% (W/V) concentration, and formed into an aerosol of an inhalation form by a conventional method by using an inert gas and a medical gas. A daily dose of the composition is 1-1,000mg and inhaled by dividing to 1-10 times. The composition can treat dyspnea caused by bronchial failure, etc., and prevent exacerbation thereof.
机译:目的:通过包含2-氨基-1-(2,5-二甲氧基苯基)1-丙醇的吸入形式来制备心脏病治疗剂。组成:目标成分是通过将2-氨基-1-(2,5-二甲氧基苯基)-1-丙醇及其盐溶解在生理溶液中以形成0.1-10%(W / V),先兆地2-5 %(W / V)浓度,并通过使用惰性气体和医用气体的常规方法形成吸入形式的气雾剂。该组合物的日剂量为1-1,000mg,并分成1-10次吸入。该组合物可以治疗由支气管衰竭等引起的呼吸困难,并防止其恶化。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号